ModelEdge

Filing Type	20-F
Filing Date	3/14/2023
Updated	3/15/23, 1:14 AM

Filing

Earnings Release

Exhibits

20-FAnnual and Transition Report of Foreign Private Issuers

EX-4.23COMPENSATION POLICY FOR EXECUTIVE OFFICERS

EX-4.24COMPENSATION POLICY FOR DIRECTORS

EX-4.25KAMADA LTD. 2011 ISRAELI SHARE AWARD PLAN

EX-4.37AMENDED AND RESTATED MANUFACTURING SERVICES AGREEMENT DATED AS OF SEPTEMBER 28, 2017, BY AND BETWEEN EMERGENT BIOSOLUTIONS, INC. AND APTEVO THERAPEUTICS INC. (ASSUMED BY KAMADA LTD.)

EX-4.38CONTRACT MANUFACTURING, SERVICES AND SUPPLY AGREEMENT DATED NOVEMBER 29, 2022, BY AND BETWEEN KAMADA LTD. AND PROTHYA BIOSOLUTIONS BELGIUM

EX-4.39SUPPLEMENTAL LETTER AGREEMENT DATED AS OF JULY 4, 2022, BY AND BETWEEN KAMADA LTD. AND TUTEUR S.A.C.I.F.I.A.

EX-4.402ND AMENDMENT TO THE DISTRIBUTION AGREEMENT, DATED AS OF FEBRUARY 22, 2023, BY AND BETWEEN KAMADA LTD. AND TUTEUR S.A.C.I.F.I.A.

EX-8.1SUBSIDIARIES OF THE REGISTRANT

EX-12.1CERTIFICATION

EX-12.2CERTIFICATION

EX-13.1CERTIFICATION

EX-15.1CONSENT OF ERNST & YOUNG GLOBAL, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM